KR100778102B1 - 재현성이 양호한 응집면역측정법 및 시약 - Google Patents
재현성이 양호한 응집면역측정법 및 시약 Download PDFInfo
- Publication number
- KR100778102B1 KR100778102B1 KR1020037002767A KR20037002767A KR100778102B1 KR 100778102 B1 KR100778102 B1 KR 100778102B1 KR 1020037002767 A KR1020037002767 A KR 1020037002767A KR 20037002767 A KR20037002767 A KR 20037002767A KR 100778102 B1 KR100778102 B1 KR 100778102B1
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- antibody
- monomer
- group represented
- immunoassay
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F230/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal
- C08F230/02—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal containing phosphorus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
- G01N33/545—Synthetic resin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
- G01N33/721—Haemoglobin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/961—Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
Description
측정회수 | 실시예 1 | 실시예2 | 비교예 1 | 비교예 2 | 비교예 3 |
1 | 6.3 | 6.3 | 6.3 | 6.3 | 6.5 |
2 | 6.4 | 6.3 | 6.4 | 6.4 | 6.4 |
3 | 6.3 | 6.3 | 6.3 | 6.3 | 6.1 |
4 | 6.3 | 6.3 | 6.4 | 6.2 | 6.3 |
5 | 6.3 | 6.3 | 6.3 | 6.6 | 6.2 |
6 | 6.4 | 6.4 | 6.5 | 6.5 | 6.4 |
7 | 6.3 | 6.3 | 6.2 | 6.2 | 6.5 |
8 | 6.3 | 6.3 | 6.2 | 6.2 | 6.3 |
9 | 6.3 | 6.3 | 6.3 | 6.3 | 6.4 |
10 | 6.3 | 6.3 | 6.4 | 6.2 | 6.4 |
평균 | 6.3 | 6.3 | 6.3 | 6.3 | 6.4 |
표준편차 | 0.040 | 0.030 | 0.090 | 0.133 | 0.120 |
동시재현성 | 0.63% | 0.48% | 1.42% | 2.10% | 1.90% |
측정회수 | 실시예 4 | 실시예 5 | 실시예 6 | 비교예 4 |
1 | 6.3 | 6.3 | 6.3 | 6.5 |
2 | 6.3 | 6.3 | 6.4 | 6.3 |
3 | 6.3 | 6.2 | 6.2 | 6.3 |
4 | 6.3 | 6.3 | 6.3 | 6.1 |
5 | 6.3 | 6.3 | 6.2 | 6.2 |
6 | 6.3 | 6.2 | 6.3 | 6.4 |
7 | 6.3 | 6.3 | 6.3 | 6.3 |
8 | 6.3 | 6.3 | 6.3 | 6.4 |
9 | 6.2 | 6.3 | 6.3 | 6.3 |
10 | 6.3 | 6.3 | 6.3 | 6.2 |
평균 | 6.3 | 6.3 | 6.3 | 6.3 |
표준편차 | 0.030 | 0.040 | 0.054 | 0.110 |
동시재현성 | 0.48% | 0.64% | 0.86% | 1.74% |
시약 | 검체 1 | 검체 2 |
실시예 4 | 6.6 | 6.1 |
실시예 8 | 6.7 | 6.5 |
실시예 9 | 6.7 | 6.7 |
비교예 4 | 6.6 | 5.1 |
Claims (22)
- 제1항에 있어서, 식(Ⅰ)로 표시되는 기를 갖는 화합물이 식(Ⅰ)로 표시되는 기를 갖는 단량체를 중합시켜서 얻어지는 화합물인 것을 특징으로 하는 응집면역측정법.
- 제1항에 있어서, 식(Ⅰ)로 표시되는 기를 갖는 화합물이 식(Ⅰ)로 표시되는 기를 갖는 단량체와, 상기 식(Ⅰ)로 표시되는 기를 갖는 단량체와 중합가능한 다른 단량체를 중합시켜서 얻어지는 화합물인 것을 특징으로 하는 응집면역측정법.
- 제3항에 있어서, 식(Ⅰ)로 표시되는 기를 갖는 단량체와 중합가능한 다른 단량체가 비닐기를 갖는 단량체인 것을 특징으로 하는 응집면역측정법.
- 제4항에 있어서, 비닐기를 갖는 단량체가 메타크릴산-n-부틸인 것을 특징으로 하는 응집면역측정법.
- 제2항 내지 제5항 중 어느 한 항에 있어서, 식(Ⅰ)로 표시되는 기를 갖는 단량체가 식(Ⅰ)로 표시되는 기와 비닐기를 갖는 단량체인 것을 특징으로 하는 응집면역측정법.
- 제1항에 있어서, 식(Ⅰ)로 표시되는 기가 포스포리콜린기인 것을 특징으로 하는 응집면역측정법.
- 제6항에 있어서, 식(Ⅰ)로 표시되는 기와 비닐기를 갖는 단량체가 2-메타크리로일옥시에틸포스포릴콜린인 것을 특징으로 하는 응집면역측정법.
- 제1항에 있어서, 항체가 항헤모글로빈A1c모노크로날항체인 응집면역측정법.
- 제1항에 있어서, 항체복합체가 항원성물질에 특이적으로 반응하는 항체와, 이것에 선택적으로 반응하는 제2항체로 이루어지는 응집면역측정법.
- 제1항에 있어서, 불용성담체가 폴리스틸렌계 라텍스인 응집면역측정법.
- 제12항에 있어서, 식(Ⅰ)로 표시되는 기를 갖는 화합물이 식(Ⅰ)로 표시되는 기를 갖는 단량체를 중합시켜 얻어지는 화합물인 것을 특징으로 하는 면역측정시 약.
- 제12항에 있어서, 식(Ⅰ)로 표시되는 기를 갖는 화합물이 식(Ⅰ)로 표시되는 기를 갖는 단량체와, 상기 식(Ⅰ)로 표시되는 기를 갖는 단량체와 중합가능한 다른 단량체를 중합시켜서 얻어지는 화합물인 것을 특징으로 하는 면역측정시약.
- 제14항에 있어서, 식(Ⅰ)로 표시되는 기를 갖는 단량체와 중합가능한 다른 단량체가 비닐기를 갖는 단량체인 것을 특징으로 하는 면역측정시약.
- 제15항에 있어서, 비닐기를 갖는 단량체가 메타크릴산-n-부틸인 것을 특징으로 하는 면역측정시약.
- 제13항 내지 제16항 중 어느 한 항에 있어서, 식(Ⅰ)로 표시되는 기를 갖는 단량체가 식(Ⅰ)로 표시되는 기와 비닐기를 갖는 단량체인 것을 특징으로 하는 면역측정시약.
- 제12항에 있어서, 식(Ⅰ)로 표시되는 기가 포스포릴콜린기인 것을 특징으로 하는 면역측정시약.
- 제17항에 있어서, 식(Ⅰ)로 표시되는 기와 비닐기를 갖는 단량체가 2-메타크 로일옥시에틸포스포릴콜린인 면역측정시약.
- 제12항에 있어서, 항체가 항 헤모글로빈A1c모노크로날항체인 것을 특징으로 하는 면역측정시약.
- 제12항에 있어서, 항체복합체가 항원성물질에 특이적으로 반응하는 항체와, 이것에 선택적으로 반응하는 제2항체로 이루어지는 것을 특징으로 하는 면역측정시약.
- 제12항에 있어서, 불용성담체가 폴리스틸렌계 라텍스인 것을 특징으로 하는 면역측정시약.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000259964 | 2000-08-29 | ||
JPJP-P-2000-00259964 | 2000-08-29 | ||
PCT/JP2001/007385 WO2002018953A1 (fr) | 2000-08-29 | 2001-08-28 | Reactifs et methode d'immunoessai d'agglutination fortement reproductible |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20030029860A KR20030029860A (ko) | 2003-04-16 |
KR100778102B1 true KR100778102B1 (ko) | 2007-11-27 |
Family
ID=18748057
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020037002767A KR100778102B1 (ko) | 2000-08-29 | 2001-08-28 | 재현성이 양호한 응집면역측정법 및 시약 |
Country Status (10)
Country | Link |
---|---|
US (1) | US7166476B2 (ko) |
EP (1) | EP1314982B1 (ko) |
JP (1) | JP4733335B2 (ko) |
KR (1) | KR100778102B1 (ko) |
CN (1) | CN1215333C (ko) |
AT (1) | ATE438097T1 (ko) |
AU (1) | AU2001280210A1 (ko) |
CA (1) | CA2420770C (ko) |
DE (1) | DE60139408D1 (ko) |
WO (1) | WO2002018953A1 (ko) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4680361B2 (ja) * | 2000-09-22 | 2011-05-11 | 一彦 石原 | 分離・回収方法 |
EP1391519B1 (en) * | 2001-04-26 | 2006-10-25 | Nof Corporation | Nonspecific hybridization inhibitors, clinical diagnostic reagents, and method of clinical analysis |
JP4577747B2 (ja) * | 2001-06-05 | 2010-11-10 | 和光純薬工業株式会社 | 免疫学的測定法用凝集促進剤 |
DE60326717D1 (de) * | 2002-12-10 | 2009-04-30 | Panasonic Corp | Immunreaktionsmessverfahren |
GB0229747D0 (en) * | 2002-12-20 | 2003-01-29 | Axis Shield Asa | Assay |
JP4241301B2 (ja) * | 2003-09-30 | 2009-03-18 | 和光純薬工業株式会社 | 免疫学的測定用試薬 |
JP3809177B2 (ja) * | 2004-05-24 | 2006-08-16 | 株式会社資生堂 | アフィニティー粒子及びアフィニティー分離方法 |
AU2005203321A1 (en) | 2004-08-03 | 2006-02-23 | Axis-Shield Diagnostics Limited | Assay |
US7846716B2 (en) | 2005-04-28 | 2010-12-07 | Fujifilm Corporation | Microchip and analysis method using the same |
ES2615524T3 (es) * | 2005-12-07 | 2017-06-07 | Sekisui Medical Co., Ltd. | Método para analizar anticuerpos anti- Treponema pallidum |
JP4629563B2 (ja) * | 2005-12-07 | 2011-02-09 | 積水メディカル株式会社 | 抗リン脂質抗体測定試薬 |
WO2009054538A1 (ja) | 2007-10-22 | 2009-04-30 | Alfresa Pharma Corporation | 免疫学的微小粒子の凝集反応を用いる検体のアクロレイン付加体の測定方法および測定用キット |
JP2008058334A (ja) * | 2007-11-21 | 2008-03-13 | Towns:Kk | イムノクロマトグラフィー用展開溶媒、測定法およびキット |
EP2483418B1 (en) * | 2009-09-30 | 2016-08-03 | Department of Biotechnology | A modified method of agglutination to detect infections caused by microorganisms |
CN101819202B (zh) * | 2010-05-06 | 2012-12-26 | 上海太阳生物技术有限公司 | D-二聚体(D-Dimer)测定试剂盒(胶乳免疫比浊法) |
CN102000067B (zh) * | 2010-09-30 | 2013-04-03 | 苏州中药研究所 | 一种蛇床子素在制备防治肺纤维化药物中的应用 |
KR20140043371A (ko) | 2011-06-07 | 2014-04-09 | 와코 쥰야꾸 고교 가부시키가이샤 | 응집촉진제 |
US9383356B2 (en) | 2012-09-27 | 2016-07-05 | Sekisui Medical Co., Ltd. | Latex particles for particle agglutination assay |
US20150316541A1 (en) * | 2013-01-16 | 2015-11-05 | Fujirebio Inc. | Method for immunologically assaying hemoglobin a1c in specimen |
FR3045834B1 (fr) | 2015-12-21 | 2021-03-05 | Biomerieux Sa | Diluant de reactifs pour immunoessai |
EP3467498B1 (en) * | 2016-05-30 | 2024-07-03 | Eiken Kagaku Kabushiki Kaisha | Anti-human hemoglobin monoclonal antibody or antibody kit, insoluble carrier particle to which anti-human hemoglobin monoclonal antibody is immobilized, and measurement reagent and measurement method using same |
CN112740037A (zh) * | 2018-09-28 | 2021-04-30 | 积水医疗株式会社 | 糖化血红蛋白(%)测定方法 |
US11327081B2 (en) | 2019-02-15 | 2022-05-10 | Siemens Healthcare Diagnostics Inc. | Calibrators and controls for the determination of percent glycated hemoglobin in a patient's liquid test sample |
JP7436838B2 (ja) | 2020-05-20 | 2024-02-22 | 藤倉化成株式会社 | 抗体-デンドリマー複合体を用いるヘモグロビンA1cの測定方法 |
CN113406323B (zh) * | 2021-06-18 | 2022-03-22 | 上海奥普生物医药股份有限公司 | 一种胶乳免疫比浊第二试剂、含其的组合及其制备方法 |
WO2024075847A1 (ja) * | 2022-10-06 | 2024-04-11 | 積水メディカル株式会社 | 非特異反応抑制剤、非特異反応抑制剤の使用方法、非特異反応抑制方法、生化学的測定用試薬、検体前処理液、及び生化学的測定用試薬キット |
WO2024140721A1 (zh) * | 2022-12-27 | 2024-07-04 | 深圳迈瑞生物医疗电子股份有限公司 | 用于检测糖化血红蛋白的试剂、检测方法及应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61274261A (ja) * | 1985-05-30 | 1986-12-04 | Nitto Electric Ind Co Ltd | 免疫学的診断試薬 |
JPS62218865A (ja) * | 1986-03-20 | 1987-09-26 | Hitachi Chem Co Ltd | リウマチ因子の定量法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS546325B2 (ko) | 1974-05-10 | 1979-03-27 | ||
JPS6047552B2 (ja) * | 1976-04-08 | 1985-10-22 | 栄研化学株式会社 | C反応性蛋白質測定用試薬 |
JPS5924387B2 (ja) * | 1977-07-27 | 1984-06-08 | 栄研化学株式会社 | リウマチ因子検出用試薬゜ |
JPS5811575A (ja) | 1981-07-13 | 1983-01-22 | Hohnen Oil Co Ltd | 耐水性接着剤 |
JPS58154591A (ja) | 1982-03-09 | 1983-09-14 | Tadao Nakaya | リン脂質類似モノマ−の製造法 |
US4609630A (en) * | 1983-03-23 | 1986-09-02 | Yanovsky Jorge F | Method for improving the specificity of immunoassays |
JPS61159166A (ja) * | 1984-12-29 | 1986-07-18 | Nitto Electric Ind Co Ltd | 免疫学的診断試薬 |
JPS62259063A (ja) * | 1986-05-02 | 1987-11-11 | Oriental Yeast Co Ltd | C−反応性蛋白質の定量方法 |
JP2677753B2 (ja) * | 1993-07-22 | 1997-11-17 | 株式会社エスアールエル | 凝集イムノアッセイ法 |
WO1996031566A1 (fr) * | 1995-04-03 | 1996-10-10 | Nof Corporation | Procede de production d'une solution aqueuse d'un groupe phosphorylcholine porteur de polymeres et solution aqueuse d'un groupe phosphorylcholine porteur de polymeres |
US5977257A (en) * | 1995-04-28 | 1999-11-02 | Nof Corporation | Polymer material, medical material and liquid high molecular composition |
JP2654932B2 (ja) * | 1995-06-16 | 1997-09-17 | オリエンタル酵母工業株式会社 | C−反応性蛋白質測定用試薬 |
JP3782851B2 (ja) | 1996-07-31 | 2006-06-07 | 日本油脂株式会社 | 蛋白質の安定化方法および組成物 |
JP3884510B2 (ja) | 1996-10-14 | 2007-02-21 | 日本油脂株式会社 | 固定化免疫学的活性物質の保存時安定化方法 |
-
2001
- 2001-08-28 DE DE60139408T patent/DE60139408D1/de not_active Expired - Lifetime
- 2001-08-28 KR KR1020037002767A patent/KR100778102B1/ko active IP Right Grant
- 2001-08-28 CA CA2420770A patent/CA2420770C/en not_active Expired - Lifetime
- 2001-08-28 EP EP01958575A patent/EP1314982B1/en not_active Expired - Lifetime
- 2001-08-28 JP JP2002523622A patent/JP4733335B2/ja not_active Expired - Lifetime
- 2001-08-28 AU AU2001280210A patent/AU2001280210A1/en not_active Abandoned
- 2001-08-28 US US10/363,038 patent/US7166476B2/en not_active Expired - Lifetime
- 2001-08-28 AT AT01958575T patent/ATE438097T1/de not_active IP Right Cessation
- 2001-08-28 CN CNB018148476A patent/CN1215333C/zh not_active Expired - Lifetime
- 2001-08-28 WO PCT/JP2001/007385 patent/WO2002018953A1/ja active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61274261A (ja) * | 1985-05-30 | 1986-12-04 | Nitto Electric Ind Co Ltd | 免疫学的診断試薬 |
JPS62218865A (ja) * | 1986-03-20 | 1987-09-26 | Hitachi Chem Co Ltd | リウマチ因子の定量法 |
Also Published As
Publication number | Publication date |
---|---|
WO2002018953A1 (fr) | 2002-03-07 |
CA2420770C (en) | 2010-05-25 |
CN1449495A (zh) | 2003-10-15 |
US7166476B2 (en) | 2007-01-23 |
US20030166302A1 (en) | 2003-09-04 |
EP1314982A1 (en) | 2003-05-28 |
EP1314982B1 (en) | 2009-07-29 |
DE60139408D1 (de) | 2009-09-10 |
EP1314982A4 (en) | 2006-06-28 |
CN1215333C (zh) | 2005-08-17 |
AU2001280210A1 (en) | 2002-03-13 |
JP4733335B2 (ja) | 2011-07-27 |
CA2420770A1 (en) | 2002-03-07 |
ATE438097T1 (de) | 2009-08-15 |
KR20030029860A (ko) | 2003-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100778102B1 (ko) | 재현성이 양호한 응집면역측정법 및 시약 | |
JP3443891B2 (ja) | タンパク質吸着防止剤 | |
US7867785B2 (en) | Carrier particle latex for assay reagent and assay reagent | |
JP5184554B2 (ja) | 検出対象の検出方法及び定量方法 | |
JP5430804B1 (ja) | 粒子凝集測定用ラテックス粒子 | |
JP2012022005A (ja) | 凝集反応安定化方法 | |
JP4853666B2 (ja) | 標的物質の検出方法、混合粒子、および標的物質の検出試薬 | |
JPH11337551A (ja) | 非特異反応抑制剤、免疫測定試薬及び免疫測定方法 | |
US20220227984A1 (en) | Particle and method for producing particle | |
CN115327121A (zh) | 凝血酶-抗凝血酶复合体的测定试剂及测定方法 | |
CN112888946B (zh) | 富含亮氨酸的α2糖蛋白的免疫测定法和测定试剂 | |
JP4240729B2 (ja) | 臨床検査用微粒子分散剤、検査用試薬、試薬の製造方法、検査方法および用途 | |
US8227263B2 (en) | Process for producing polymer particles | |
EP2088429B1 (en) | Reagent and method for immunological analysis | |
WO2019031581A1 (ja) | 免疫凝集の検出又は測定方法 | |
EP2902785B1 (en) | Latex particles for particle aggregation measurement | |
JP2947600B2 (ja) | 免疫測定法 | |
EP2309268A1 (en) | Method for immunoassay using latex particles | |
CN111239403A (zh) | 一种β2微球蛋白胶乳增强免疫比浊试剂盒及应用 | |
JP3644704B2 (ja) | 免疫測定法 | |
EP3951389A1 (en) | Immunoassay reagent and immunoassay method | |
JPS63221245A (ja) | 抗原−抗体反応の測定方法 | |
JPH03281510A (ja) | 診断薬用担体用ポリマー粒子の製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
N231 | Notification of change of applicant | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121105 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20131104 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20141021 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20151016 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20161019 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20171018 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20181018 Year of fee payment: 12 |